World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
97
Citations
33714
World Ranking
9305
National Ranking
4800

Alan B. Cantor publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Alan B. Cantor sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 353 publications — 28th percentile

28% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Alan B. Cantor D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Alan B. Cantor sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 97 D-Index — 55th percentile

55% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Alan B. Cantor is affiliated with Harvard University in the United States. Their research primarily spans the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with significant contributions in subfields including Molecular Biology, Hematology, Genetics, Cancer Research, and Cell Biology.

The scientist's work covers various topics in biomedical research with a focus on Acute Myeloid Leukemia Research, Epigenetics and DNA Methylation, Platelet Disorders and Treatments, Myeloproliferative Neoplasms: Diagnosis and Treatment, Zebrafish Biomedical Research Applications, Breast Cancer Treatment Studies, and Blood disorders and treatments.

Alan B. Cantor has published several recent papers across different venues. Notable publications include:

  • A phase II study of continuous oral mTOR inhibitor everolimus for recurrent, radiographic-progressive neurofibromatosis type 1-associated pediatric low-grade glioma: a Neurofibromatosis Clinical Trials Consortium study, 2020, Neuro-Oncology
  • The RUNX1 database (RUNX1db): establishment of an expert curated RUNX1 registry and genomics database as a public resource for familial platelet disorder with myeloid malignancy, 2021, Haematologica
  • Common variants in signaling transcription-factor-binding sites drive phenotypic variability in red blood cell traits, 2020, Nature Genetics
  • Role of RUNX Family Transcription Factors in DNA Damage Response., 2020, PubMed
  • Infantile Myelofibrosis and Myeloproliferation with CDC42Dysfunction, 2020, Journal of Clinical Immunology

Frequent publication venues for Cantor's work include Blood, Experimental Hematology, Blood Advances, bioRxiv (Cold Spring Harbor Laboratory), and UNC Libraries.

The scientist has collaborated repeatedly with certain colleagues, including Nah-Young Shin, Michael W. Drazer, Lucy A. Godley, Anna Brown, and Claire C. Homan.

Best Publications

  • Lymphatic mapping and sentinel node biopsy in the patient with breast cancer

    John J. Albertini;Gary H. Lyman;Charles Cox;Tim Yeatman

  • Human Fetal Hemoglobin Expression Is Regulated by the Developmental Stage-Specific Repressor BCL11A

    Vijay G. Sankaran;Tobias F. Menne;Jian Xu;Thomas E. Akie

  • Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma

    Akira Nakagawara;Miwako Arima-Nakagawara;Nancy J. Scavarda;Christopher G. Azar

  • BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases

    Tuya Pal;Jenny Permuth-Wey;A R N Judith Betts;Jeffrey P. Krischer

  • Discovery of JSI-124 (cucurbitacin I), a selective Janus kinase/signal transducer and activator of transcription 3 signaling pathway inhibitor with potent antitumor activity against human and murine cancer cells in mice.

    Michelle A. Blaskovich;Jiazhi Sun;Alan Cantor;James Turkson

  • Transcriptional regulation of erythropoiesis: an affair involving multiple partners.

    Alan B Cantor;Stuart H Orkin;Stuart H Orkin

  • A Myc Network Accounts for Similarities between Embryonic Stem and Cancer Cell Transcription Programs

    Jonghwan Kim;Andrew J. Woo;Jianlin Chu;Jonathan W. Snow

  • Constitutive Activation of Stat3 in Human Prostate Tumors and Cell Lines Direct Inhibition of Stat3 Signaling Induces Apoptosis of Prostate Cancer Cells

    Linda B Mora;Ralf Buettner;John Seigne;Jose Diaz

  • Targeted Deletion of a High-Affinity GATA-binding Site in the GATA-1 Promoter Leads to Selective Loss of the Eosinophil Lineage In Vivo

    Channing Yu;Alan B. Cantor;Haidi Yang;Carol Browne

  • The uncertainty principle and industry-sponsored research

    Benjamin Djulbegovic;Mensura Lacevic;Alan Cantor;Karen K Fields

  • Osteopontin identified as lead marker of colon cancer progression, using pooled Sample expression profiling

    Deepak Agrawal;Tingan Chen;Rosalyn Irby;John Quackenbush

  • RRM1 Modulated In Vitro and In Vivo Efficacy of Gemcitabine and Platinum in Non–Small-Cell Lung Cancer

    Gerold Bepler;Irina Kusmartseva;Swati Sharma;Ashish Gautam

  • Indoleamine 2,3-dioxygenase contributes to tumor cell evasion of T cell-mediated rejection.

    Maria Friberg;Ronald Jennings;Marwan Alsarraj;Sophie Dessureault

  • Lysophospholipids are potential biomarkers of ovarian cancer.

    Rebecca Sutphen;Yan Xu;George D Wilbanks;James Fiorica

  • Molecular Staging for Survival Prediction of Colorectal Cancer Patients

    Steven Eschrich;Ivana Yang;Greg Bloom;Ka Yin Kwong

  • ERCC1 Expression Is a Predictor of Survival in Resected Patients With Non-small Cell Lung Cancer

    George R Simon;Swati Sharma;Alan Cantor;Prudence Smith

  • Activation of Stat3 in Primary Tumors from High-Risk Breast Cancer Patients Is Associated with Elevated Levels of Activated Src and Survivin Expression

    Nills Diaz;Susan Minton;Charles Cox;Tammy Bowman

  • Insights into GATA-1 Mediated Gene Activation versus Repression via Genome-wide Chromatin Occupancy Analysis

    Ming Yu;Laura Riva;Huafeng Xie;Yocheved Schindler

  • The Efficacy and Safety of Pain Management Before and After Implementation of Hospital-Wide Pain Management Standards: Is Patient Safety Compromised by Treatment Based Solely on Numerical Pain Ratings?

    Hector Vila;Robert A. Smith;Michael J. Augustyniak;Peter A. Nagi

  • The relationship between age and the fatty acid composition of cerebral cortex and erythrocytes in human subjects

    Jane D. Carver;Valerie J. Benford;Beth Han;Alan B. Cantor

Frequent Co-Authors

Stuart H. Orkin
Stuart H. Orkin Harvard University
Charles E. Cox
Charles E. Cox University of South Florida
Barry H. Paw
Barry H. Paw Brigham and Women's Hospital
Douglas S. Reintgen
Douglas S. Reintgen University of South Florida
Eric B. Haura
Eric B. Haura University of South Florida
Daniel E. Bauer
Daniel E. Bauer Harvard University
Leonard I. Zon
Leonard I. Zon Harvard University
Jane L. Messina
Jane L. Messina University of South Florida
Scott J. Antonia
Scott J. Antonia Duke University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re planning to study Medicine in the USA, there are several online degree options and career pathways to consider—especially in the field of nursing. For practicing nurses aiming for advanced practice roles, some of the cheapest dnp programs make achieving a terminal nursing degree more affordable and accessible.

Students with an RN can look into affordable rn to bsn programs to advance their credentials without leaving their current jobs. These flexible online programs often feature lower tuition and convenient schedules, making them ideal for working professionals.

If you have a non-nursing bachelor’s degree but dream of entering the nursing profession, there are direct entry msn programs for non-nursing majors that streamline your path toward a master’s degree in nursing.

Those seeking the quickest and most accessible way into nursing should also review the online bsn programs for non nurses designed to be less competitive and more straightforward to gain admission.

Best Scientists Citing Alan B. Cantor

Trending Scientists

Recently Published Articles